Company / EPS (Diluted)
LEXICON PHARMACEUTICALS, INC. EPS (Diluted) History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.80
FY2025
5-year range
-$1.27 / $1.16
FY2021-FY2025
Trend
-29.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has declined for 3 consecutive years, from $1.16 in FY2019 to $-0.80 in FY2025.
Based on SEC 10-K filings.
-0.80 in FY2025.
Declined from $-0.60 to $-0.80 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LEXICON PHARMACEUTICALS, INC.'s eps (diluted) has declined for 3 consecutive years.
- In FY2025, eps (diluted) decreased 29.0% year-over-year.
- Peak eps (diluted) was recorded in FY2019.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.80 | -29.0% |
| FY2024 | -$0.62 | -3.3% |
| FY2023 | -$0.60 | -151.7% |
| FY2019 | $1.16 | +191.3% |
| FY2018 | -$1.27 | -2440.0% |
| FY2017 | -$0.05 | +96.2% |
| FY2016 | -$1.31 | -385.2% |
| FY2015 | -$0.27 | -17.4% |
| FY2014 | -$0.23 | +32.4% |
| FY2013 | -$0.34 | +0.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026